Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Samara, I. Lasithiotaki, G. Soufla, I. Giannarakis, M. Velivassaki, A. Psaraki, N. Siafakas, K. Antoniou (Heraklion, Greece). Telomerase expression in idiopathic pulmonary fibrosis (IPF) and non small cell lung cancer (NSCLC). Eur Respir J 2012; 40: Suppl. 56, 702

Member's Comments

No comment yet.

Related content which might interest you: Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005 The prevalence of bronchogenic lung cancer (BLC) in patients with idiopathic pneumonic fibrosis (IPF) Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003 SFTPA mutations in interstitial lung disease (ILD) and lung cancer Source: International Congress 2017 – Rare diseases Year: 2017 Regulation and localization of the telomerase enzyme-complex and the shelterin-telosom-complex in sporadic idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Lung cancer as a comorbidity in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012 Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 WFDC2 (HE4) and SLPI are differentially expressed in normal and diseased human lung and in lung cancer Source: Annual Congress 2006 - Molecular airway biology Year: 2006 A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Interstitial fibrosis with a nodule Source: Annual Congress 2007 - Thoracic Oncology Grand Round: an interactive session Year: 2007 Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016 Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests Source: Eur Respir J 2002; 20: Suppl. 38, 106s Year: 2002 The association of lung cancer with pulmonary fibrosis Source: ERJ Open Res, 8 (1) 00505-2021; 10.1183/23120541.00505-2021 Year: 2022 The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Heterogeneous reactivity of ICAM-1 on alveolar macrophages (AMs) in patients with non-small cell lung cancer (NSCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003